Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-373|1|939|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-524|1|573|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-545|1|745|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-551|1|655|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-552|1|827|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology 
|23-1-1-553|1|914|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-554|1|932|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-555|1|978|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm0,MPATH: 549 - carcinoma|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-561|1|830|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-564|1|991|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-571|1|965|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-584|1|580|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-585|1|747|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-591|1|788|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-593|1|888|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-594|1|602|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-601|1|795|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-603|1|817|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-605|1|503|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-611|1|848|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-614|1|725|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm0,MPATH: 268 - adenocarcinoma|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-625|1|858|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-633|1|564|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-641|1|663|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-643|1|852|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-651|1|904|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, extrapulmonary metastasis , lymphnodes involved,MPATH: 446 - squamous cell carcinoma|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-652|1|575|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-653|1|404|Other deterministic changes|Lower respiratory system|n/a|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-661|1|882|Neoplasia benign|Lower respiratory system|Tumoursize2-5mm0|
23-1-1|n/a,n/a|1| 52|Pu-239 dioxide|450|becquerels|Inhalation| 450 ± 130 Bq .5 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) .

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|30 (30 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-1-663|1|788|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-382|2|968|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm0,MPATH: 446 - squamous cell carcinoma|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-383|2|724|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-384|2|724|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-452|2|986|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-511|2|766|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-512|2|528|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-513|2|600|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-521|2|713|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-531|2|560|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-562|2|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-563|2|750|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-565|2|915|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-573|2|778|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-574|2|872|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-581|2|796|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-582|2|635|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-583|2|713|Other deterministic changes|Lower respiratory system|, extrapulmonary metastasis , lymphnodes involved|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-592|2|850|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-595|2|749|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-602|2|549|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-613|2|859|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-615|2|879|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-621|2|761|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-622|2|488|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, spread to pleura 0,MPATH: 268 - adenocarcinoma|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-632|2|732|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-655|2|704|Other deterministic changes|Lower respiratory system|n/a|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-662|2|813|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-2|n/a,n/a|1| 52|Pu-239 dioxide|630|becquerels|Inhalation| 630 ± 130Bq 3.6 ± 0.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7)

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|28 (28 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-2-665|2|795|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-372|3|622|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-374|3|930|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-375|3|734|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-385|3|934|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-391|3|968|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm0,MPATH: 549 - carcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-393|3|696|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-401|3|636|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-433|3|889|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-471|3|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-481|3|573|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-484|3|881|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-491|3|784|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm0,MPATH: 549 - carcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-493|3|838|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-501|3|932|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-502|3|886|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-503|3|900|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-505|3|782|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm0,MPATH: 549 - carcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-515|3|846|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-522|3|902|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, extrapulmonary metastasis , lymphnodes involved,MPATH: 446 - squamous cell carcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-523|3|803|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-533|3|876|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 268 - adenocarcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-535|3|991|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-541|3|657|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-544|3|906|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-575|3|529|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-612|3|971|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-623|3|740|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-624|3|468|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-631|3|938|Other deterministic changes|Lower respiratory system|n/a|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-635|3|750|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm, extrapulmonary metastasis , lymphnodes involved,MPATH: 549 - carcinoma|
23-1-3|n/a,n/a|1| 52|Pu-239 dioxide|825|becquerels|Inhalation| 825 ± 230 Bq 5 ± 0.5 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) or NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|31 (31 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-3-645|3|815|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-371|4|870|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-381|4|812|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-394|4|845|Neoplasia benign|Lower respiratory system|Tumoursize 0-2mm0|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-403|4|832|Neoplasia benign|Lower respiratory system|Tumoursize2-5mm0|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-411|4|792|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-412|4|631|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-413|4|717|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm, extrapulmonary metastasis , lymphnodes involved,MPATH: 549 - carcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-421|4|663|Neoplasia benign|Lower respiratory system|Tumoursize2-5mm0|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-423|4|600|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-425|4|951|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-435|4|728|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-442|4|828|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-444|4|832|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-445|4|818|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-451|4|540|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-453|4|691|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-455|4|837|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, spread to pleura 0,MPATH: 268 - adenocarcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-461|4|517|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-463|4|832|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-464|4|784|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, extrapulmonary metastasis , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-465|4|709|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-472|4|848|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-473|4|406|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-474|4|947|Other deterministic changes|Lower respiratory system|, extrapulmonary metastasis , lymphnodes involved|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-482|4|933|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm0,MPATH: 268 - adenocarcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-485|4|757|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm0,MPATH: 268 - adenocarcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-492|4|778|Neoplasia benign|Lower respiratory system|Tumoursize 5-10mm0|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-494|4|916|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm0,MPATH: 268 - adenocarcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-495|4|725|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-504|4|817|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-514|4|866|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm0,MPATH: 268 - adenocarcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-525|4|690|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-542|4|889|Other deterministic changes|Lower respiratory system|n/a|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-654|4|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-4|n/a,n/a|1| 52|Pu-239 dioxide|1330|becquerels|Inhalation| 1330 ± 440 Bq 8.2 ± 1.6 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|35 (35 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-4-725|4|608|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm, extrapulmonary metastasis , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-253|5|708|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm0,MPATH: 549 - carcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-255|5|816|Other deterministic changes|Lower respiratory system|n/a|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-284|5|850|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, extrapulmonary metastasis , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-292|5|763|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-315|5|989|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-323|5|792|Other deterministic changes|Lower respiratory system|n/a|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-325|5|533|Other deterministic changes|Lower respiratory system|n/a|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-402|5|761|Other deterministic changes|Lower respiratory system|n/a|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-405|5|593|Other deterministic changes|Lower respiratory system|n/a|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-414|5|658|Other deterministic changes|Lower respiratory system|n/a|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-422|5|609|Other deterministic changes|Lower respiratory system|n/a|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-424|5|864|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 561 - adenosquamous carcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-431|5|628|Other deterministic changes|Lower respiratory system|n/a|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-432|5|824|Neoplasia benign|Lower respiratory system|Tumoursize 5-10mm, extrapulmonary metastasis , lymphnodes involved|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-441|5|818|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, spread to pleura 0,MPATH: 268 - adenocarcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-443|5|770|Other deterministic changes|Lower respiratory system|n/a|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-454|5|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm0,MPATH: 446 - squamous cell carcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-462|5|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-483|5|614|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, spread to pleura , intra+extra pulmonary metastasis0,MPATH: 446 - squamous cell carcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-642|5|820|Other deterministic changes|Lower respiratory system|n/a|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-675|5|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-684|5|881|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-694|5|855|Neoplasia benign|Lower respiratory system|Tumoursize2-5mm0|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-714|5|396|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, extrapulmonary metastasis , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-715|5|742|Neoplasia benign|Lower respiratory system|Tumoursize2-5mm0|
23-1-5|n/a,n/a|1| 52|Pu-239 dioxide|2235|becquerels|Inhalation| 2235 ± 610 Bq 14 ± 1.3 Gy Inhalation of  industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|26 (26 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-5-722|5|838|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, extrapulmonary metastasis , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-271|6|634|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-283|6|464|Other deterministic changes|Lower respiratory system|n/a|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-311|6|891|Neoplasia benign|Lower respiratory system|Tumoursize 0-2mm0|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-331|6|881|Neoplasia benign|Lower respiratory system|Tumoursize2-5mm0|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-335|6|857|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm0,MPATH: 268 - adenocarcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-434|6|837|Other deterministic changes|Lower respiratory system|n/a|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-671|6|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm0,MPATH: 561 - adenosquamous carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-672|6|953|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-673|6|791|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm0,MPATH: 268 - adenocarcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-674|6|754|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, extrapulmonary metastasis , lymphnodes involved,MPATH: 561 - adenosquamous carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-681|6|898|Other deterministic changes|Lower respiratory system|n/a|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-682|6|818|Neoplasia benign|Lower respiratory system|Tumoursize2-5mm0|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-683|6|783|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-685|6|708|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 268 - adenocarcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-691|6|874|Neoplasia benign|Lower respiratory system|Tumoursize >10mm, extrapulmonary metastasis , lymphnodes involved|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-692|6|663|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm0,MPATH: 446 - squamous cell carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-693|6|452|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm0,MPATH: 446 - squamous cell carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-694|6|n/a|Neoplasia benign|Lower respiratory system|Tumoursize2-5mm0|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-701|6|755|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-702|6|673|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-703|6|833|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-704|6|740|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-711|6|512|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm0,MPATH: 549 - carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-712|6|851|Other deterministic changes|Lower respiratory system|, extrapulmonary metastasis , lymphnodes involved|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-713|6|849|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, spread to pleura 0,MPATH: 561 - adenosquamous carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-721|6|965|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm0,MPATH: 549 - carcinoma|
23-1-6|n/a,n/a|1| 52|Pu-239 dioxide|3310|becquerels|Inhalation| 3310 ± 620 Bq 22.5 ± 6.4 Gy Inhalation of industrial PuO2 (AMAD 2.4 µm, gsd 1.7) 

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|27 (27 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-6-724|6|461|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-722|7|632|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-733|7|921|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-734|7|671|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-735|7|810|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-763|7|499|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-812|7|718|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-814|7|542|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-815|7|679|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-821|7|498|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-823|7|781|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-824|7|812|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-833|7|734|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-852|7|707|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-853|7|687|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, intrapulmonary metastasis , lymphnodes involved,MPATH: 549 - carcinoma|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-865|7|887|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-911|7|698|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-912|7|859|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-914|7|650|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-922|7|910|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 268 - adenocarcinoma|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-924|7|842|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm, lymphnode involved , lymphnodes involved,MPATH: 549 - carcinoma|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-931|7|949|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-934|7|637|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-935|7|916|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-942|7|930|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-943|7|907|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-944|7|860|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-952|7|569|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-953|7|776|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-954|7|663|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-955|7|561|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-961|7|629|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-963|7|589|Other deterministic changes|Lower respiratory system|n/a|
23-1-7|n/a,n/a|1| 52|Np-237 dioxide|100|becquerels|Inhalation| 100 ± 30Bq 0.5 ± 0.1Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|33 (33 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-7-964|7|750|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-312|8|432|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-314|8|982|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-315|8|712|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-322|8|954|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-323|8|960|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-324|8|744|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-325|8|964|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-332|8|831|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, lymphnode involved , lymphnodes involved,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-333|8|690|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-334|8|908|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-335|8|960|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-341|8|726|Neoplasia benign|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-342|8|775|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-343|8|911|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-344|8|528|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-345|8|799|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-351|8|502|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-352|8|501|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, spread to pleura ,MPATH: 268 - adenocarcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-353|8|801|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-354|8|747|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-355|8|600|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-361|8|614|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-362|8|754|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-363|8|738|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-364|8|722|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-365|8|768|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-413|8|728|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-414|8|835|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-415|8|821|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-422|8|770|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-423|8|990|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-424|8|573|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-425|8|745|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-431|8|850|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-432|8|590|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-433|8|626|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-434|8|621|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-435|8|693|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-441|8|860|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-442|8|781|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-444|8|794|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-445|8|653|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-452|8|671|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-453|8|843|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-454|8|799|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-455|8|460|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-461|8|829|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-462|8|719|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-463|8|612|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-464|8|751|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-465|8|867|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-542|8|564|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-552|8|769|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 268 - adenocarcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-555|8|707|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-565|8|773|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-711|8|782|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-712|8|813|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-714|8|826|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-715|8|639|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-721|8|727|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-723|8|964|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-724|8|601|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-725|8|737|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-731|8|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-732|8|781|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-741|8|935|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-742|8|721|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-743|8|653|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-744|8|624|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-745|8|714|Other deterministic changes|Lower respiratory system|, lymphnode involved , lymphnodes involved|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-751|8|919|Neoplasia benign|Lower respiratory system|Tumoursize 5-10mm|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-754|8|826|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-761|8|763|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-762|8|699|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-764|8|671|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-765|8|813|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-811|8|780|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-822|8|876|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-825|8|805|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-831|8|599|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-832|8|762|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-834|8|665|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-835|8|631|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-841|8|512|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-842|8|986|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-843|8|658|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, intrapulmonary metastasis ,MPATH: 446 - squamous cell carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-844|8|755|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-845|8|641|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-851|8|613|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-854|8|853|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-855|8|781|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-861|8|824|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-862|8|760|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, lymphnode involved , lymphnodes involved,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-863|8|876|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-864|8|902|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 268 - adenocarcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-915|8|699|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-923|8|587|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-925|8|737|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-941|8|916|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-951|8|782|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-962|8|884|Other deterministic changes|Lower respiratory system|n/a|
23-1-8|n/a,n/a|1| 52|Np-237 dioxide|190|becquerels|Inhalation| 190 ± 60 Bq 1.1 ± 0.3 Bq Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|102 (102 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-8-1243|8|896|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, intrapulmonary metastasis ,MPATH: 268 - adenocarcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-255|9|759|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-541|9|842|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, lymphnode involved , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-543|9|872|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-544|9|541|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-545|9|693|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-551|9|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-553|9|601|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-554|9|661|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, intrapulmonary metastasis , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-561|9|752|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-562|9|751|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-563|9|893|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-564|9|681|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, intrapulmonary metastasis , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1213|9|874|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm,MPATH: 268 - adenocarcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1214|9|599|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1222|9|668|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1223|9|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1224|9|603|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1231|9|579|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, intrapulmonary metastasis , lymphnodes involved,MPATH: 446 - squamous cell carcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1235|9|724|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1241|9|658|Other deterministic changes|Lower respiratory system|n/a|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1242|9|811|Neoplasia benign|Lower respiratory system|Tumoursize 5-10mm|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1245|9|883|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm,MPATH: 268 - adenocarcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1251|9|900|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-9|n/a,n/a|1| 52|Np-237 dioxide|800|becquerels|Inhalation| 800 ± 265 Bq 4.1 ± 0.9 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-9-1252|9|873|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-145|10|808|Other deterministic changes|Lower respiratory system|n/a|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-214|10|581|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 268 - adenocarcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-231|10|589|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, intrapulmonary metastasis ,MPATH: 268 - adenocarcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-232|10|849|Other deterministic changes|Lower respiratory system|n/a|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-241|10|507|Other deterministic changes|Lower respiratory system|n/a|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-245|10|572|Other deterministic changes|Lower respiratory system|n/a|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-262|10|646|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 561 - adenosquamous carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-263|10|799|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1212|10|901|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1215|10|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1221|10|841|Other deterministic changes|Lower respiratory system|, lymphnode involved , lymphnodes involved|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1225|10|599|Other deterministic changes|Lower respiratory system|n/a|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1232|10|761|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, intrapulmonary metastasis ,MPATH: 268 - adenocarcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1233|10|951|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, intrapulmonary metastasis , lymphnodes involved,MPATH: 549 - carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1234|10|731|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1244|10|701|Other deterministic changes|Lower respiratory system|n/a|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1253|10|804|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1254|10|825|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1255|10|705|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, intrapulmonary metastasis ,MPATH: 268 - adenocarcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1261|10|713|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, intrapulmonary metastasis , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1262|10|672|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1263|10|777|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, intrapulmonary metastasis ,MPATH: 549 - carcinoma|
23-1-10|n/a,n/a|1| 52|Np-237 dioxide|1520|becquerels|Inhalation| 1520 ± 490 Bq 7.7 ± 1.4 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-10-1264|10|517|Other deterministic changes|Lower respiratory system|n/a|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-115|11|680|Other deterministic changes|Lower respiratory system|n/a|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-123|11|648|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-132|11|453|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, lymphnode involved , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-133|11|800|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, intrapulmonary metastasis ,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-141|11|579|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-142|11|528|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-151|11|667|Other deterministic changes|Lower respiratory system|n/a|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-161|11|549|Other deterministic changes|Lower respiratory system|n/a|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-162|11|740|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-212|11|779|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, spread to pleura ,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-213|11|798|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, lymphnode involved , lymphnodes involved,MPATH: 561 - adenosquamous carcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-215|11|773|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm, intrapulmonary metastasis ,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-221|11|814|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, intrapulmonary metastasis,MPATH: 549 - carcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-223|11|686|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-224|11|583|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 549 - carcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-233|11|603|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 446 - squamous cell carcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-234|11|819|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, intrapulmonary metastasis , lymphnodes involved,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-235|11|671|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-243|11|891|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm, intrapulmonary metastasis ,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-252|11|748|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-253|11|608|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-254|11|749|Other deterministic changes|Lower respiratory system|n/a|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-264|11|766|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize >10mm, intrapulmonary metastasis ,MPATH: 268 - adenocarcinoma|
23-1-11|n/a,n/a|1| 52|Np-237 dioxide|2660|becquerels|Inhalation| 2660 ± 690 Bq 14.5 ± 3.3 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-11-1265|11|812|Other deterministic changes|Lower respiratory system|n/a|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-112|12|499|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 268 - adenocarcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-114|12|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 268 - adenocarcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-117|12|n/a|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize2-5mm,MPATH: 268 - adenocarcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-124|12|740|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 0-2mm,MPATH: 549 - carcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-125|12|519|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 268 - adenocarcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-131|12|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 446 - squamous cell carcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-143|12|747|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm,MPATH: 268 - adenocarcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-144|12|554|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 561 - adenosquamous carcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-153|12|597|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 446 - squamous cell carcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-155|12|752|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 268 - adenocarcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-164|12|743|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 268 - adenocarcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-165|12|582|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 268 - adenocarcinoma|
23-1-12|n/a,n/a|1| 52|Np-237 dioxide|2680|becquerels|Inhalation| 3680 ± 950 Bq 36.4 ± 10.2 Gy Inhalation of industrial NpO2 (AMAD 2.6 µm, gsd 2.2).

Specific activity ratio of Pu vs. Np = 580 determination of individual lung deposits|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|23-1-12-222|12|538|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|Tumoursize 5-10mm, spread to pleura ,MPATH: 561 - adenosquamous carcinoma|
23-1-13|n/a,n/a|Sequence:1, Age:52,Type:none (controls),Quantity:0,Unit:becquerels,Application:not applicable or not supplied, Remarks:Controls|795 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Juvenile|Lifespan study (spontaneous death) with macroscopic/microscopic pathology|No information on individuals available for this study
		
